News

ExxonMobil affiliates have signed an agreement to sell all of ExxonMobil’s interests in the Aera oil-production operation in California to Green Gate Resources E, LLC, a subsidiary of IKAV.

The

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to two upcoming webcasts of Pfizer discussions at healthcare conferences:

• 
  Mikael Dolsten, Chief Scientific

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a 30-µg booster dose of their Omicron BA.1 Bivalent COVID-19 Vaccine (COMIRNATY^® Original/Omicron BA.1 15/15 µg) has been

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) of a 30-µg booster dose of the

Chevron Corporation (NYSE: CVX), one of the world’s leading energy companies, announced today the launch of the Chevron Exchange Q&A Series, starting with a virtual fireside chat with Chief

NIKE, Inc. (NYSE: NKE) plans to release its first quarter fiscal 2023 financial results on Thursday, September 29, 2022, at approximately 1:15 p.m. PT, following the close of regular stock market

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for a booster dose of an Omicron BA.4/BA.5-adapted

Mike Wirth, chairman and CEO of Chevron Corporation (NYSE: CVX), will take part in the Barclays CEO Energy-Power Conference on Wednesday, September 7, 2022, at 8:00 AM ET, discussing corporate

Pfizer Inc. (NYSE: PFE) today announced positive top-line data from the Phase 3 clinical trial (NCT05035212) RENOIR (RSV vaccine Efficacy study iN Older adults Immunized against RSV disease)

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced updated efficacy results from a Phase 2/3 trial evaluating a three 3-µg dose series of the Pfizer-BioNTech COVID-19 Vaccine in

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA)

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Mikael Dolsten, Chief Scientific Officer, President, Worldwide Research

American Express Company (NYSE: AXP) Vice Chairman and Chief Financial Officer Jeffrey C. Campbell will participate in the Barclays Global Financial Services Conference on Monday, September 12

Walmart Inc. (NYSE: WMT):

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220815005707/en/

Second-quarter highlights:

• 
  Company

Pfizer Inc. (NYSE:PFE) today announced positive top-line results from its pivotal U.S. Phase 3 study (NCT04382326) in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate

Walmart Inc. (NYSE: WMT) today announced it will hold a live conference call with the Investment Community at 7 a.m. CDT Tuesday, Aug. 16, 2022, to discuss the company’s second quarter earnings

Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR)

Pfizer Inc. (NYSE: PFE) and Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the companies have entered into a definitive agreement under which Pfizer will acquire GBT, a

NIKE, Inc. (NYSE: NKE) announced today that its Board of Directors has declared a quarterly cash dividend of $0.305 per share on the Company’s outstanding Class A and Class B Common Stock payable

American Express (NYSE: AXP) today released its 2021-2022 Environmental, Social and Governance (ESG) Report. The report highlights the company’s progress on its ESG strategy and roadmap announced

Chevron Corporation (NYSE: CVX) today announced the appointment of Alana K. Knowles as vice president and controller, effective March 1, 2023. Knowles will succeed David A. Inchausti, who will

Exxon Mobil Corporation (NYSE:XOM):

Results Summary

2Q22

1Q22

Change

vs

1Q22

2Q21

Change

vs

2Q21

Chevron Corporation (NYSE: CVX) today reported earnings of $11.6 billion ($5.95 per share - diluted) for second quarter 2022, compared with $3.1 billion ($1.60 per share - diluted) in second

Pfizer Inc. (NYSE: PFE) reported strong financial results for second-quarter 2022 and updated certain components of 2022 financial guidance⁽⁴⁾. Pfizer reaffirmed its previous 2022 revenue guidance

The Board of Directors of Chevron Corporation (NYSE: CVX) declared a quarterly dividend of one dollar and forty-two cents ($1.42) per share, payable September 12, 2022, to all holders of common